Buccal fentanyl may be valid option during placement of indwelling central venous access port
the ONA take:
Fentanyl buccal tablet is a valid, practical, and safe method of procedural analgesia for patients with cancer during placement of indwelling central venous access systems, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Although local anesthesia is most commonly used to overcome pain related to the procedural placement of fully implantable venous access systems in patients with cancer, it may not eradicate all pain. Therefore, researchers sought to evaluate the effectiveness and safety of fentanyl buccal tablet in reducing procedural pain related to the placement of the port in opioid-naïve patients.
For the study, researchers enrolled 65 inpatients who required an indwelling vascular access port. Patients received a 100-mcg fentanyl buccal tablet 10 minutes before preparation of the operating field.
Results showed that nearly 94% of patients experienced no or little pain during the procedure. Only four patients reported a lot of pain, and no patients reported very severe pain.
In regard to safety, 43.1% experienced drowsiness, 9.2% experienced nausea, and 4.7% experienced vomiting, at the end of the procedure. Four hours after the procedure, the rates of drowsiness, nausea, and vomiting were 12.5%, 10.9%, and 7.8%, respectively.
“It will be necessary to perform further studies, taking into account the need for standard antiemetic premedication to [minimize] the incidence of nausea and vomiting,” the authors conclude.
Fentanyl buccal tablet is a valid, practical, and safe method of procedural analgesia for patients with cancer.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|